Darvocet Heart Problems: The Root of Liability Lawsuits
A controversial painkiller approved by the FDA during the 1950’s, Darvocet has been plagued from the very start by questions regarding the safety of its usage. Darvocet heart problems, particularly, have caused many plaintiffs to file a Darvocet or Darvon lawsuit. According to their Darvocet lawyer, the drug, also known as propoxyphene, can result in serious Darvocet side effects such as abnormal heart rhythm, heart attack, stroke, and even death.
Darvocet heart problems prompt FDA action
Propoxyphene is a narcotic pain reliever and cough suppressant. Weaker than morphine, it is used for the treatment of mild to moderate pain. In November of 2010, the FDA finally took action in response to the large number of complaints from patients who had suffered Darvocet heart problems. At that time, many had already hired a Darvocet lawyer. Since the agency ordered a ban against the drugs, even more have filed a Darvon lawsuit.
Darvocet lawyer points to Darvocet side effects
Since 1981, there have been more than 2,000 confirmed cases of accidental death caused by Darvocet heart problems, or overdose. Additionally, a number of injured patients have consulted a Darvocet lawyer complaining of arrhythmia, ventricular fibrillation and tachycardia, heart attack, stroke, or Torsade de Pointes (TdP). In filing a Darvocet or Darvon lawsuit, many plaintiffs have pointed to an arrhythmia as an initial side effect, which can eventually lead to more serious, sometimes fatal, Darvocet heart problems.
Darvocet heart problems prompt FDA ban
The FDA ban on Darvocet, Darvon, and similar drugs came almost six years after the drugs were taken off the market in the U.K., and more than a year after they were banned by the European Medicines Agency (EMA). Victims of Darvocet heart problems, through their Darvocet lawyer, have criticized the FDA for not erring on the side of caution and immediately banning the drugs after a slew of complaints from users. In light of the FDA ban, Darvocet users are encouraged by the agency to consult their physicians immediately, even if they do not yet experience any symptoms. It is not advisable to suddenly stop the use of Darvocet unless recommended by a doctor.
- Queens woman, Kristine Esposito sues drug-maker Xanodyne over heart arrhythmia from Darvocet. http://www.nydailynews.com/new-york/queens-woman-kristine-esposito-sues-drug-maker-xanodyne-heart-arrhythmia-darvocet-article-1.474633
- Xanodyne agrees to withdraw propoxyphene from the U.S. market. http://www.fda.gov/NewsEvents/Newsroom/Press